Endurant Capital Management’s DexCom DXCM Stock Holding History

Endurant Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-20,694	Closed	-$1.93M	–	37
2023 Q3	$1.93M	Buy	+20,694	New	+$2.33M	1.73%	22
2023 Q2	–	Sell	-22,185	Closed	-$2.58M	–	46
2023 Q1	$2.58M	Buy	+22,185	New	+$2.48M	1.32%	22
2022 Q3	–	Sell	-26,046	Closed	-$1.94M	–	56
2022 Q2	$1.94M	Buy	+26,046	New	+$2.38M	0.68%	34

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Endurant Capital Management's DXCM Position: Q4 2023 in Review

Endurant Capital Management sold out of DexCom (DXCM) in Q4 2023, closing a stake of 20,694 shares — an estimated $1.93M sold.

Endurant Capital Management first reported a position in DXCM in Q2 2022 and held it in 3 quarters. The position peaked at $2.58M in Q1 2023. 974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

Endurant Capital Management reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
Endurant Capital Management sold 20,694 DexCom shares in Q4 2023, an estimated $1.93M.
Endurant Capital Management first reported a position in DexCom in Q2 2022 and held it in 3 quarters.
Endurant Capital Management's DexCom position peaked at $2.58M in Q1 2023.
974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Endurant Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.